Clinical Trial Spotlight: Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC?

GRACE Videos and Articles

LCAM 2015

 

Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.

[powerpress]

[ratingwidget post_id=0]

Check out more LCAM videos & posts here.

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation